Delivery Order SPE2DB22D2206-SPE2DB24FJW04
Award Date
8/19/24
Potential Completion Date
9/10/24
Potential Value
$14K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VEKLURY (Remdesivir) 100 mg vials. The contract has a ceiling value of $2,377.32 and a period of performance through May 14, 2025. It is a firm-fixed-price contract, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VEKLURY (Remdesivir) 100 mg vials. The delivery order is valued at $13,618.40 and has a completion date of April 12, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
The Defense Logistics Agency (DLA) awarded a $4,085.52 firm-fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of 100 mg VEKLURY (Remdesivir) vials. This order was placed under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation. As a major...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $27,213.60 firm fixed-price delivery order is for the supply of VEKLURY (Remdesivir) 100 mg vials. The contract has a completion date of July 26, 2022 and does not include any set-aside requirements. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for...
This contract award to AmerisourceBergen Drug Corp is a delivery order worth $6,809.20 for the supply of Veklury (remdesivir) 100 mg vials. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. The contract has an ultimate completion date of October 2, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor. This award is likely part of a larger Indefinite Delivery Contract (IDC) the company holds...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Veklury (Remdesivir) 100 mg vials. The $20,427.60 firm fixed price contract has an ultimate completion date of October 29, 2024. This award is a task order under AmerisourceBergen's Indefinite Delivery Contract valued up to $999,999,999 with DLA Troop Support Medical for a wide range of pharmaceutical and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $2,042.76 firm fixed-price delivery order is for the supply of Veklury (Remdesivir) 100 mg vials, a key therapeutic used to treat COVID-19. The contract has an ultimate completion date of October 21, 2024. AmerisourceBergen, a large pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VEKLURY (remdesivir) 100 mg vials. The contract, valued at $15,848.80, is a firm fixed-price delivery order that runs through March 11, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the delivery of Veklury (Remdesivir) 100 mg vials. The contract, valued at $2,042.76, is a delivery order with a firm fixed price and an ultimate completion date of October 21, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract to supply the critical COVID-19 treatment drug to support military treatment facilities and other federal...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,754.64, is for the delivery of the drug VEKLURY (Remdesivir) 100 mg vials. It is a firm fixed-price contract with a completion date of June 2, 2025. The contract is not set aside for any particular business type. AmerisourceBergen Drug Corp holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support...